Bio

Prof. Dr. Sergi X. Trilla is a distinguished biopharmaceutical executive and medical doctor with over 30 years of experience in the healthcare industry. He has a proven track record in corporate strategy and business development in Biotech, MedTech and digital health. As the founder and President of Trifermed, Sergi has been instrumental in transforming innovative ideas into market-ready solutions, leveraging his profound understanding of translational medicine. Under his leadership, Trifermed has orchestrated over 200 global strategic partnerships and expanded its operations to North America, establishing headquarters in Cambridge, MA. Sergi’s executive experience includes pivotal roles such as Chief Business Officer at Veru, where he spearheaded international market entries and strategic shifts, and Chief Strategy Officer at Intrommune Therapeutics, where he transformed the company's business model and initiated fundraising efforts. His strategic vision and operational acumen have consistently driven growth and innovation. In addition to his corporate roles, Sergi is an Adjunct Faculty member at the ADA Forsyth Institute in Cambridge, MA, and has been a mentor and educator at ESADE Business School. He also serves as a Senior Business Advisor for HIPRA and MEDISCA, further showcasing his extensive expertise and influence in the healthcare sector. His contributions to the academic and professional communities have been recognized through various awards, including the Trifermed Awards for Social Impact in Health. Sergi’s multidisciplinary expertise, coupled with his passion for advancing healthcare solutions, makes him an invaluable asset to Achelos as it continues to drive innovation in the life science sector.